[CME-Lab 2/Solution. Hypercholesteremia and therapy control].
von Eckardstein
A
A
Institut für Klinische Chemie, Universitätsspital Zürich. arnold.voneckardstein@usz.ch
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D000069059:Atorvastatin; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004347:Drug Interactions; D005500:Follow-Up Studies; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D020902:Hypericum / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011758:Pyrroles / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D011758:Pyrroles; D014280:Triglycerides; D002784:Cholesterol; D000069059:Atorvastatin